SPYRE THERAPEUTICS, INC. (SYRE)
Clinical trial NCT06622070 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-08 → 2026-07-28 3. primary completion date: 2026-04-03 → 2026-07-28 4. enrollment: 56 → 40 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical